Two Payers among 5 fast-growing Healthcare stocks

Some of the most comprehensive healthcare companies of The US have not only expanded their revenue per share but also Ebitda per share by 10% over the preceding five years, which have made them appealing to the investors’ eyes. It includes two payers.

1. UnitedHealth Group Inc :UnitedHealth Group Inc.’s revenue per share and Ebitda per share have increased 10.20% and 14.70%, respectively, over the past five years. Over a 10-year period, they grew by 13.10% and 12.80%. The company’s largest shareholder is Vanguard Health Care Fund followed by Dodge & Cox and Steve Mandel. It has a market cap of $369.63 billion and an enterprise value of $392.97 billion. The price-book ratio is 5.33. The share price has been as high as $393.92 and as low as $273.25 in the last year; it is currently 0.74% below its 52-week high and 43.10% above its 52-week low.
2. Thermo Fisher Scientific Inc: Over the past five years, Thermo Fisher Scientific Inc. has seen its revenue increase 13.20% and its Ebitda rise 19.60%. Over a 10-year period, the increases were 10.90% and 16.30%, respectively. The company’s largest shareholder is PRIMECAP Management, followed by Vanguard Health Care Fund, BAILLIE GIFFORD & CO, and Pioneer Investments. The company, which provides scientific instruments and laboratory equipment, has a market cap of $193.73 billion and an enterprise value of $205.14 billion.
3. CSL Ltd: The revenue per share of CSL Ltd. has grown by 14.70% and its Ebitda per share has increased by 14.60% over a five-year period. Over the past 10 years, the metrics increased by 15.60% and 15.40%, respectively. The biotech company has a market cap of $95.30 billion and an enterprise value of $99.02 billion. The company’s largest shareholder is Ken Fisher.
4. Humana Inc: Over a five-year period, the revenue per share and Ebitda per share of Humana Inc. has grown by 10.10% and 16.70%, respectively. Over a 10-year period, the company has reported a growth of 10.50% for its Ebitda and 10.60% for its revenue. The company’s largest guru shareholder is the Vanguard Health Care Fund followed by Mandel and Jim Simons Renaissance Technologies. The U.S. private health insurer has a market cap of $56.16 billion and an enterprise value of $58.46 billion.
5. M3 Inc: M3 Inc. registered a five-year performance for its revenue per share of 19.80% and for its Ebitda per share of 16.60%. Over a 10-year period, the growth rates were 28.10% and 19.90%, respectively. The company, which provides medical-related services, has a market cap of $53.10 billion and an enterprise value of $52.30 billion.